Patents by Inventor Yuzuru Umeda

Yuzuru Umeda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8541468
    Abstract: There are provided an ophthalmic composition that comprises 3-hydroxybutyric acid and/or salts thereof as active ingredients and is used to prevent desiccation of eyes and an ophthalmic composition that is used to treat tear dysfunction. By use of the ophthalmic compositions of the present invention, desiccation of the eyes can be inhibited and tear dysfunction can be treated. Therefore, by use of the compositions, discomforts caused by tear dysfunction, such as desiccation of the eyes, foreign-body sensation, feeling of discomfort on the eyes and eye strain, can be improved. Further, the ophthalmic compositions of the present invention can inhibit diseases caused by tear dysfunction, exemplified by development of dry eye and suspected dry eye which are dysfunctions related to desiccation of the eyes, particularly, development of diseases caused by tear dysfunction without injuries on the keratoconjunctive.
    Type: Grant
    Filed: September 30, 2004
    Date of Patent: September 24, 2013
    Assignee: Ophtecs Corporation
    Inventors: Yuzuru Umeda, Hideo Nakashima, Michiko Shibuya, Yasukazu Saitoh, Shoji Okada, Shigeru Nakamura
  • Publication number: 20070225369
    Abstract: There are provided an ophthalmic composition that comprises 3-hydroxybutyric acid and/or salts thereof as active ingredients and is used to prevent desiccation of eyes and an ophthalmic composition that is used to treat tear dysfunction. By use of the ophthalmic compositions of the present invention, desiccation of the eyes can be inhibited and tear dysfunction can be treated. Therefore, by use of the compositions, discomforts caused by tear dysfunction, such as desiccation of the eyes, foreign-body sensation, feeling of discomfort on the eyes and eye strain, can be improved. Further, the ophthalmic compositions of the present invention can inhibit diseases caused by tear dysfunction, exemplified by development of dry eye and suspected dry eye which are dysfunctions related to desiccation of the eyes, particularly, development of diseases caused by tear dysfunction without injuries on the keratoconjunctive.
    Type: Application
    Filed: September 30, 2004
    Publication date: September 27, 2007
    Applicant: Ophtecs Corporation
    Inventor: Yuzuru Umeda
  • Publication number: 20050074467
    Abstract: A liquid formulation for contact lenses which comprises polylysine, polyphosphoric acid and/or salt thereof as a substance for suppressing the adhesion of polylysine to a contact lens, nitrogen-containing organic anti-microbial agent excluding polylysine and water. Contact lenses can be cleaned, disinfected and stored simply by soaking them in the liquid formulation without cleaning by digital rubbing or without rinsing before they are worn in eyes.
    Type: Application
    Filed: January 31, 2003
    Publication date: April 7, 2005
    Inventors: Masaaki Fujita, Chihiro Nakamichi, Shinji Nishimura, Yuzuru Umeda, Motoharu Tajiri, Fumio Saito